Canlyniadau Chwilio - Lorenza Rimassa

Mireinio'r Canlyniadau
  1. 1
    Navigating the new landscape of second‐line treatment in advanced hepatocellular carcinoma

    Navigating the new landscape of second‐line treatment in advanced hepatocellular carcinoma gan Lorenza Rimassa, Marcus‐Alexander Wörns

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    <p>Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date</p>

    <p>Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date</p> gan Nicola Personeni, Tiziana Pressiani, Lorenza Rimassa

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Systemic Treatment Options in Hepatocellular Carcinoma

    Systemic Treatment Options in Hepatocellular Carcinoma gan Lorenza Rimassa, Tiziana Pressiani, Philippe Merle

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Molecular therapies for HCC: Looking outside the box

    Molecular therapies for HCC: Looking outside the box gan Sandrine Faivre, Lorenza Rimassa, Richard S. Finn

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Combination immunotherapy for hepatocellular carcinoma

    Combination immunotherapy for hepatocellular carcinoma gan Lorenza Rimassa, Richard S. Finn, Bruno Sangro

    Cyhoeddwyd 2023
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma

    Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma gan Lorenza Rimassa, Romano Danesi, Tiziana Pressiani, Philippe Merle

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment

    Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment gan Masatoshi Kudo, Franco Trevisani, Ghassan K. Abou‐Alfa, Lorenza Rimassa

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights

    Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights gan Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa, Silvia Bozzarelli

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Systemic treatment of HCC in special populations

    Systemic treatment of HCC in special populations gan Lorenza Rimassa, Nicola Personeni, Carolin Czauderna, Friedrich Foerster, Peter R. Galle

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

    Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab gan Chiun Hsu, Lorenza Rimassa, Hui‐Chuan Sun, Arndt Vogel, Ahmed O. Kaseb

    Cyhoeddwyd 2021
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma

    ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma gan Coşkun Özer Demirtas, Antonio D’Alessio, Lorenza Rimassa, Rohini Sharma, David J. Pinato

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Role of molecular genetics in the clinical management of cholangiocarcinoma

    Role of molecular genetics in the clinical management of cholangiocarcinoma gan Nicola Normanno, Erika Martinelli, Davide Melisi, Carmine Pinto, Lorenza Rimassa, Daniele Santini, Aldo Scarpa

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?

    Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? gan Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David J. Pinato, Lorenza Rimassa

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design

    Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design gan Robin Kate Kelley, Jennifer Oliver, Saswati Hazra, Fawzi Benzaghou, Thomas Yau, Ann‐Lii Cheng, Lorenza Rimassa

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper

    Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper gan Matteo Fassan, Valentina Angerilli, Nicola Normanno, Giancarlo Pruneri, Antonio Marchetti, Federica Grillo, Giuseppe Tonini, Aldo Scarpa, Lorenza Rimassa

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice

    Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice gan Giuseppe Cabibbo, Ciro Celsa, Lorenza Rimassa, Ferrán Torres, Jordi Rimola, Roman Kloeckner, Jordi Bruix, Calogero Cammà, María Reig

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options

    Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options gan Nicola Personeni, Ana Lleó, Tiziana Pressiani, Francesca Colapietro, Mark R. Openshaw, Chara Stavraka, Athanasios Pouptsis, David J. Pinato, Lorenza Rimassa

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

    5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors gan Emilio Bajetta, Lorenza Rimassa, Carlo Carnaghi, Ettore Seregni, Leonardo Ferrari, Maria Di Bartolomeo, Enrico Regalia, Antonio Cassata, Giuseppe Procopio, Luigi Mariani

    Cyhoeddwyd 1998
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Immune-based therapies for hepatocellular carcinoma

    Immune-based therapies for hepatocellular carcinoma gan David J. Pinato, Nadia Guerra, Petros Fessas, Ravindhi Murphy, Takashi Mineo, Francesco Mauri, Sujit Mukherjee, Mark Thursz, Ching Ngar Wong, Rohini Sharma, Lorenza Rimassa

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up gan Arndt Vogel, John Bridgewater, Julien Edeline, Robin Kate Kelley, Heinz‐Josef Klümpen, David Malka, John Primrose, Lorenza Rimassa, Albrecht Stenzinger, Juan W. Valle, Michel Ducreux

    Cyhoeddwyd 2022
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: